The Pharmaceuticals sector of United Kingdom witnessed 2 Private Equity/Venture Financing deals in July 2022, for an aggregate deal value of $5.0 million. This represents a decrease of 99.7% in terms of value and a decrease of 77.0% in terms of volume, year over year.
A total of 57 Private Equity/Venture Financing deals were recorded over the last twelve months (LTM) for an aggregate deal value of $2,308.6 million. In the LTM period, February 2022, turned out to be the most prolific in terms of deal size, with a total deal value of $96.4 million and a deal volume of 2 during that month. On the other hand, the month of February 2022, was the most prolific in terms of deal volume, recording a total of 2 deals with a total deal value of $607,356.1 million during that month.
On an average, over the LTM period, 4 deals were done with an average deal size of $192.4 million.
United States of America
China
Switzerland
United States of America
United States of America
United States of America
United States of America
Germany
France
Switzerland
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer
Contact the team or request a demo to find out how our data can drive your business forward